Literature DB >> 339933

The effects of atenolol and propranolol upon lipolysis.

S P Deacon.   

Abstract

1 The effects of selective and non-selective beta-adrenoceptor blockade upon plasma non-esterified fatty acid concentrations in the fasting state and following insulin stress have been studied in normal subjects. 2 Atenolol, propranolol and placebo were compared in a double-blind cross-over trial in eight normal subjects. 3 Atenolol and propranolol significantly lowered plasma non-esterified fatty acid concentrations by a similar degree in the fasting, non-stressed state. This finding suggests that beta1-adrenoceptors are involved in the control of basal lipolysis. 4 Following insulin-induced stress, lower plasma non-esterified fatty acid concentrations were observed with propranolol than with atenolol. This difference may be due to beta2-adrenoceptor involvement in the stress mechanisms controlling lipolysis, or to the differences in the water-lipid solubility properties of these drugs.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 339933      PMCID: PMC1429255          DOI: 10.1111/j.1365-2125.1978.tb01611.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  12 in total

1.  Effects of metoprolol and propranolol on some metabolic responses to catecholamines in the anaesthetized dog.

Authors:  B Ablad; I Börjesson; E Carlsson; G Johnsson
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1975

2.  Titration of free fatty acids of plasma: a study of current methods and a new modification.

Authors:  D L TROUT; E H ESTES; S J FRIEDBERG
Journal:  J Lipid Res       Date:  1960-04       Impact factor: 5.922

3.  Plasma epinephrine and norepinephrine levels during insulin-induced hypoglycemia in man.

Authors:  A GOLDFIEN; R MOORE; S ZILELI; L L HAVENS; L BOLING; G W THORN
Journal:  J Clin Endocrinol Metab       Date:  1961-03       Impact factor: 5.958

4.  Effect of adrenergic blockade on glucose and fatty-acid mobilisation in man.

Authors:  T R PILKINGTON; R D LOWE; B F ROBINSON; E TITTERINGTON
Journal:  Lancet       Date:  1962-08-18       Impact factor: 79.321

5.  Effects of small intravenous doses of epinephrine on serum insulin, glucose tolerance and serum free fatty acids.

Authors:  P V Cardon; J L Weiss; P S Mueller
Journal:  Diabetes       Date:  1974-09       Impact factor: 9.461

6.  Effects of lipolytic and antilipolytic substances on adenosine 3',5'-monophosphate levels in isolated fat cells.

Authors:  R W Butcher; C E Baird; E W Sutherland
Journal:  J Biol Chem       Date:  1968-04-25       Impact factor: 5.157

Review 7.  Sympathetic regulation of metabolism.

Authors:  J Himms-Hagen
Journal:  Pharmacol Rev       Date:  1967-09       Impact factor: 25.468

Review 8.  Biochemical aspects of drug and hormone action on adipose tissue.

Authors:  J N Fain
Journal:  Pharmacol Rev       Date:  1973-03       Impact factor: 25.468

9.  A new type of cardioselective adrenoceptive blocking drug.

Authors:  A M Barrett; J Carter; J D Fitzgerald; R Hull; D Le Count
Journal:  Br J Pharmacol       Date:  1973-06       Impact factor: 8.739

Review 10.  Differentiation of receptors activated by catecholamines. 3.

Authors:  A Arnold
Journal:  Farmaco Sci       Date:  1972-01
View more
  16 in total

1.  Comparison of beta-adrenoceptor blockers under maximal exercise (pindolol v metoprolol v atenolol).

Authors:  J Erikssen; E Thaulow; R Mundal; P Opstad; S Nitter-Hauge
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

Review 2.  [The influence of beta-receptor blockers on metabolism (author's transl)].

Authors:  F W Lohmann
Journal:  Klin Wochenschr       Date:  1981-01-15

3.  The effect of metoprolol on plasma lipids.

Authors:  I W Beinart; D G Cramp; R M Pearson; C W Havard
Journal:  Postgrad Med J       Date:  1979-10       Impact factor: 2.401

Review 4.  Exercise performance and beta-blockade.

Authors:  P A Tesch
Journal:  Sports Med       Date:  1985 Nov-Dec       Impact factor: 11.136

Review 5.  Atenolol: a review of its pharmacological properties and therapeutic efficacy in angina pectoris and hypertension.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1979-06       Impact factor: 9.546

6.  A comparison between propranolol, practolol and betaxolol (SL75212) on the circulatory and metabolic responses to insulin-induced hypoglycaemia.

Authors:  J Saunders; R Gomeni; J R Kilborn; P L Morselli; P H Sönksen
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

7.  Effect of timolol maleate on pacing induced myocardial ischaemia.

Authors:  K Daly; P J Richardson; G Bergman; L Atkinson; S Kerkez; D E Jewitt
Journal:  Br Heart J       Date:  1984-12

8.  Effects of beta-adrenoceptor blockade on exercise performance and respiratory response in healthy, physically untrained humans.

Authors:  B Violante; G Buccheri; V Brusasco
Journal:  Br J Clin Pharmacol       Date:  1984-12       Impact factor: 4.335

9.  Influence of propranolol on uptake of radioiodinated heptadecanoic acid and thallium-201 in the dog heart.

Authors:  E E van der Wall; G Westera; M J van Eenige; S Scholtalbers; F C Visser; W den Hollander; J P Roos
Journal:  Eur J Nucl Med       Date:  1983

10.  Haemodynamic and metabolic effects of atenolol in patients with angina pectoris.

Authors:  D S Thompson; N Naqvi; S M Juul; D J Coltart; B S Jenkins; M M Webb-Peploe
Journal:  Br Heart J       Date:  1980-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.